IDEXX Laboratories Inc/ US45168D1046 /
| 5/31/2024 10:00:00 PM | Chg. -2.8200 | Volume | Bid11:37:08 PM | Ask11:37:08 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 496.9500USD | -0.56% | 935,445 Turnover: 279.87 mill. |
480.0000Bid Size: 200 | 536.0000Ask Size: 200 | 41.04 bill.USD | - | 48.86 |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 10.17 USD | 25.25% |
| EPS Diluted: | 10.06 USD | 25.28% |
| Revenues per Share: | 44.06 USD | 8.48% |
| Book Value per Share: | 17.87 USD | 143.32% |
| Cash Flow per Share: | 10.91 USD | 66.58% |
| Dividend per Share: | - USD | - |
| Total | in mill. | |
| Revenues: | 3,660.95 USD | 8.72% |
| Net Income: | 845.04 USD | 24.44% |
| Operating Cash Flow: | 906.51 USD | - |
| Cash and Cash Equivalents: | 453.93 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 48.86 | 54.58 |
| P/S Ratio: | 11.28 | 12.60 |
| P/BV ratio: | 27.81 | 31.07 |
| P/CF Ratio: | 45.55 | 50.88 |
| PEG: | 1.94 | 2.16 |
| Earnings Yield: | 2.05% | 1.83% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 41.04 bill. USD | 46.12 bill. USD |
| Free Float Market Cap.: | - USD | - USD |
| Market Cap. / Employee: | - USD | - USD |
| Shares Outstanding: | 82.59 mill. | |
Profitability
| Gross Profit Margin: | 59.82% |
| EBIT Margin: | 29.97% |
| Net Profit Margin: | 23.08% |
| Return on Equity: | 56.92% |
| Return on Assets: | 25.92% |
Financial Strength
| Liquidity I / Cash Ratio: | 47.70% |
| Liquidity II / Quick Ratio: | 95.78% |
| Liquidity III / Current Ratio: | 157.14% |
| Debt / Equity Ratio: | 119.59% |
| Dynam. Debt / Equity Ratio: | 195.85% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 12/31/2023 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
